首页 | 本学科首页   官方微博 | 高级检索  
     


Heterogeneous histological pattern of membranoproliferative glomerulonephritis associated with alternative pathway abnormalities in human
Affiliation:1. Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK;2. Centre for Complement and Inflammation Research, Department of Medicine, Imperial College Hammersmith Campus, London, UK;3. INSERM, UMR-S 1064, and Department of Nephrology and Immunology, CHU de Nantes, Nantes, France;4. Department of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA;5. Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France;6. Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA;7. Division of Nephrology, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA;8. IRCCS–Istituto di Ricerche Farmacologiche “Mario Negri,” Clinical Research Center for Rare Diseases “Aldo e Cele Daccò,” Ranica, Bergamo, Italy;9. Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain; Centro de Investigación Biomédica en Enfermedades Raras, Madrid, Spain;10. Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1138, Complément et Maladies, Centre de Recherche des Cordeliers, Paris, France;11. Université Paris Descartes Sorbonne Paris-Cité, Paris, France;12. Université Pierre et Marie Curie (UPMC-Paris-6), Paris, France;13. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA;1. Department of Nephrology and Immunology, Center Hospitalier Universitaire de Nantes, Nantes, France;2. Department of Pathology, Center Hospitalier Universitaire de Nantes, Nantes, France;3. Centre de Recherche en Transplantation et en Immunologie, UMR 1064, INSERM, Université de Nantes, France;4. Department of Nephology, CHU Angers, Angers, France;5. Department of Nephrology and Renal Transplantation, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, INSERM U955, Université Paris Est Créteil, Paris, France;6. Department of Nephrology, CHU Rouen, Rouen, France;7. Department of Nephrology, CHU Bordeaux, Bordeaux, France;8. Department of Nephrology and Internal Medicine, Centre Hospitalier de Valenciennes, Valenciennes, France;9. Department of Nephrology, Centre Hospitalier de Boulogne-sur-Mer, Boulogne sur Mer, France;10. Department of Nephrology, Hôpital Européen Georges-Pompidou, Université Paris Descartes, Paris, France;11. Department of Nephrology, CHU Bichat, Paris, France;12. Department of Nephrology, CHU Amiens, Amiens, France;13. Department of Nephrology, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France;14. Department of Nephrology, CHU Rennes, Rennes, France;15. Department of Nephrology, CHU Tours, Tours, France;16. Department of Nephrology, Groupe Hospitalier Universitaire Pitié-Salpêtrière, Paris, France;17. Department of Nephrology, Centre Hospitalier de Saint Nazaire, Saint Nazaire, France;18. Department of Nephrology, Centre Hospitalier de Saint Malo, Saint Malo, France;19. Department of Nephrology, CHU Poitiers, Poitiers, France;20. Centre ECHO, Site Confluent-Rezé, Nantes, France;21. Department of Nephrology, CHU Montpellier, Montpellier, France;1. Brigham and Women''s Hospital, Boston, Massachusetts, USA;2. The University of Queensland and Princess Alexandra Hospital, Brisbane, Australia;3. Ghent University Hospital, Ghent, Belgium;4. PAREXEL International, Waltham, Massachusetts, USA;5. Columbia University Medical Center, New York, New York, USA;1. Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SDI/LEDI, France;2. Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SER/UEM, France;3. Institut Gustave Roussy, Service de Radiothérapie Oncologique, France;4. Centre Chirurgical Marie-Lannelongue, Service de Radiologie, France;5. Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PRP-HOM/SRBE/LEPID, France;1. Division of Hematology/Oncology, Department of Medicine, UCSF Medical Center, San Francisco, CA;2. UCSF Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center, San Francisco, CA;3. Department of Hematology, Intermountain Healthcare, Salt Lake City, UT;4. Medical Science Liaison, Adaptive Biotechnologies, Seattle, WA;5. Department of Radiology, UCSF Medical Center, San Francisco, CA;6. Department of Epidemiology and Biostatistics, UCSF Medical Center, San Francisco, CA;1. Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany;2. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada;3. Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;4. Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy;5. European Institute of Oncology, Milan, Italy;6. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;7. Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;8. Department of Urology, University of Jordan, Amman, Jordan;9. Department of Urology, McGill University Health Centre, Montréal, Québec, Canada;10. Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Colombia, Canada
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号